A review of the safety and efficacy of current COVID-19 vaccines

被引:0
|
作者
Zehong Huang
Yingying Su
Tianying Zhang
Ningshao Xia
机构
[1] Xiamen University,State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Strait Collaborative Innovation Center of Biomedicine and Pharmaceutics, School of
来源
Frontiers of Medicine | 2022年 / 16卷
关键词
COVID-19; SARS-CoV-2; vaccine; safety; efficacy; effectiveness; immunogenicity;
D O I
暂无
中图分类号
学科分类号
摘要
Vaccination is the most effective and feasible way to contain the Coronavirus disease 2019 (COVID-19) pandemic. The rapid development of effective COVID-19 vaccines is an extraordinary achievement. This study reviewed the efficacy/effectiveness, immunogenicity, and safety profile of the 12 most progressed COVID-19 vaccines and discussed the challenges and prospects of the vaccine-based approaches in a global crisis. Overall, most of the current vaccines have shown safety and efficacy/effectiveness during actual clinical trials or in the real-world studies, indicating a development of pandemic control. However, many challenges are faced by pandemic control in terms of maximizing the effect of vaccines, such as rapid vaccine coverage, strategies to address variants with immune escape capability, and surveillance of vaccine safety in the medium- and long-terms.
引用
收藏
页码:39 / 55
页数:16
相关论文
共 50 条
  • [31] COVID-19 vaccines in patients with cancer: immunogenicity, efficacy and safety
    Fendler, Annika
    de Vries, Elisabeth G. E.
    GeurtsvanKessel, Corine H.
    Haanen, John B.
    Wormann, Bernhard
    Turajlic, Samra
    von Lilienfeld-Toal, Marie
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2022, 19 (06) : 385 - 401
  • [32] COVID-19 vaccines in patients with cancer: immunogenicity, efficacy and safety
    Annika Fendler
    Elisabeth G. E. de Vries
    Corine H. GeurtsvanKessel
    John B. Haanen
    Bernhard Wörmann
    Samra Turajlic
    Marie von Lilienfeld-Toal
    [J]. Nature Reviews Clinical Oncology, 2022, 19 : 385 - 401
  • [33] Safety and efficacy of COVID-19 vaccines in people with neurological disorders
    Wood, Heather
    [J]. NATURE REVIEWS NEUROLOGY, 2022, 18 (02) : 66 - 66
  • [34] Safety and efficacy of COVID-19 vaccines in people with neurological disorders
    Heather Wood
    [J]. Nature Reviews Neurology, 2022, 18 : 66 - 66
  • [35] Safety and efficacy of COVID-19 vaccines in multiple sclerosis patients
    Kelly, Hannah
    Sokola, Brent
    Abboud, Hesham
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 2021, 356
  • [37] Safety and Efficacy of COVID-19 Vaccines: A Systematic Review and Meta-Analysis of Different Vaccines at Phase 3
    Fan, Yu-Jing
    Chan, Kwok-Hung
    Hung, Ivan Fan-Ngai
    [J]. VACCINES, 2021, 9 (09)
  • [38] Safety and efficacy of COVID-19 vaccines in children and adolescents: A systematic review of randomized controlled trials
    Tian, Fangyuan
    Yang, Ruonan
    Chen, Zhaoyan
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2022, 94 (10) : 4644 - 4653
  • [39] Evaluation of the safety profile of COVID-19 vaccines: a rapid review
    Qianhui Wu
    Matthew Z. Dudley
    Xinghui Chen
    Xufang Bai
    Kaige Dong
    Tingyu Zhuang
    Daniel Salmon
    Hongjie Yu
    [J]. BMC Medicine, 19
  • [40] A comparative analysis on the safety and efficacy of Covaxin versus other vaccines against COVID-19: a review
    Talukder, Abhijita
    Kalita, Chayanika
    Neog, Nayanika
    Goswami, Chayanika
    Sarma, Mrinal Kashyap
    Hazarika, Iswar
    [J]. ZEITSCHRIFT FUR NATURFORSCHUNG SECTION C-A JOURNAL OF BIOSCIENCES, 2022, 77 (7-8): : 351 - 362